143 related articles for article (PubMed ID: 29323247)
1. Leakage correction improves prognosis prediction of dynamic susceptibility contrast perfusion MRI in primary central nervous system lymphoma.
Kim YS; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH
Sci Rep; 2018 Jan; 8(1):456. PubMed ID: 29323247
[TBL] [Abstract][Full Text] [Related]
2. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
3. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
5. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
6. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
[TBL] [Abstract][Full Text] [Related]
7. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
8. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous perfusion and permeability assessments using multiband multi-echo EPI (M2-EPI) in brain tumors.
Wu J; Saindane AM; Zhong X; Qiu D
Magn Reson Med; 2019 Mar; 81(3):1755-1768. PubMed ID: 30298595
[TBL] [Abstract][Full Text] [Related]
10. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Meling TR; Latysheva A; Da Broi M; Jahr G; Holte H; Beiske K; Emblem KE
Neuroradiology; 2018 Jul; 60(7):703-713. PubMed ID: 29804159
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy.
Chen C; Zhuo H; Wei X; Ma X
Contrast Media Mol Imaging; 2019; 2019():5481491. PubMed ID: 31777472
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.
Toh CH; Wei KC; Chang CN; Ng SH; Wong HF
AJNR Am J Neuroradiol; 2013; 34(6):1145-9. PubMed ID: 23348763
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
Bathla G; Soni N; Endozo R; Ganeshan B
Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.
Lee EK; Choi SH; Yun TJ; Kang KM; Kim TM; Lee SH; Park CK; Park SH; Kim IH
Korean J Radiol; 2015; 16(6):1341-8. PubMed ID: 26576125
[TBL] [Abstract][Full Text] [Related]
17. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.
Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA
J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931
[TBL] [Abstract][Full Text] [Related]
18. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
20. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
Stokes AM; Semmineh N; Quarles CC
Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
